M Natrajan Selected Research

Borderline Leprosy

1/2017	Addition of Mycobacterium indicus pranii vaccine as an immunotherapeutic to standard chemotherapy in borderline leprosy: a double-blind study to assess clinical improvement (preliminary report).
10/2012	Clinical and histopathological evaluation of the effect of addition of immunotherapy with Mw vaccine to standard chemotherapy in borderline leprosy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

M Natrajan Research Topics

Disease

7	Leprosy (Hansen's Disease) 01/2013 - 01/2000
3	Tuberculosis (Tuberculoses) 03/2017 - 01/2009
2	Infections 04/2018 - 01/2013
2	Borderline Leprosy 01/2017 - 10/2012
1	Disease Progression 01/2013
1	Granuloma 10/2012

Drug/Important Bio-Agent (IBA)

3	AerosolsIBA 04/2018 - 01/2009
2	VaccinesIBA 01/2017 - 01/2009
2	Pharmaceutical PreparationsIBA 06/2005 - 10/2000
2	Minocycline (Cyclops)FDA LinkGeneric 10/2000 - 01/2000
1	Chemokine CXCL12IBA 04/2018
1	CXC ChemokinesIBA 04/2018
1	Streptomycin (Streptomycin Sulfate)FDA Link 03/2017
1	Ethambutol (Myambutol)FDA LinkGeneric 03/2017
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 01/2013
1	CytokinesIBA 01/2013
1	ChemokinesIBA 01/2013
1	Mycobacterium w vaccineIBA 10/2012
1	AcidsIBA 07/2012
1	Ofloxacin (Ofloxacine)FDA LinkGeneric 10/2000
1	Adenosine Triphosphate (ATP)IBA 10/2000
1	Therapeutic UsesIBA 10/2000
1	PefloxacinIBA 01/2000

Therapy/Procedure

5	Drug Therapy (Chemotherapy) 04/2018 - 01/2000
1	Retreatment 03/2017
1	Immunotherapy 10/2012
1	Therapeutics 06/2005